KIT and mantle cell lymphoma: MCL typically shows positivity for at least some SM‐markers, such as CD2, CD25, CD30, CD117, and Tryptase expression, highlighting the importance of performing a complete immunophenotypic panel in similar cases to highlight mast cell derivation of the underlying immature process.